Lakewood-Amedex Biotherapeutics Inc. (LABT) — Dilution Risk Analysis
Current Snapshot
Lakewood-Amedex Biotherapeutics Inc. (LABT) has a DilutionWatch score of 70/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 70/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
2 shelf registration or ATM offering filings detected in recent history.
Recent filing forms in the source payload: EFFECT 1, SC 13G 3, 424B3 2, XBRL 1.
| Form | Filed | Accession |
|---|---|---|
| EFFECT | 2026-09-24 | 9999999995-26-003056 |
| SC 13G | 2026-08-14 | 0001174947-26-000808 |
| SC 13G | 2026-08-06 | 0001213900-26-086054 |
| SC 13G | 2026-06-23 | 0001213900-26-070922 |
| 424B3 | 2026-06-22 | 0001213900-26-070620 |
| 424B3 | 2026-06-22 | 0001213900-26-070622 |
| xbrl | 2025-12-31 | xbrl-7801-xbrl_convertible |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 11 months | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 70/10) Source
- Cash Runway
- 11 months Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.